to answer some of my own questions.
CANVAS is a double-blind trial, meaning patients, investigators, doctors administering the treatment are blinded. This means that someone independent of all this needs to be involved in managing the trial
this is referred to as a data safety monitoring committee
you can read up about one here
http://en.wikipedia.org/wiki/Data_monitoring_committee
igcs abstract, page-11
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 805 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 169 | 1 |
View Market Depth
| Last trade - 09.58am 20/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable